Who benefits from an influenza vaccination of GPs?

Vaccine

Volumn 20, Issue 1-2, 2001, Pages 1-2

  Michiels, Barbara ^a   Coenen, Samuel ^a   Avonts, Dirk ^a   Van Royen, Paul ^a   Denekens, Joke ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTATION; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; EPIDEMIC; GENERAL PRACTICE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; LETTER; PHYSICIAN; PRIORITY JOURNAL; REACTION TIME; SEROCONVERSION; SYMPTOM; VIRUS GENOME; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ADULT; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; OCCUPATIONAL EXPOSURE; PHYSICIANS, FAMILY; RISK; VACCINATION;

EID: 0035850993     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00255-9     Document Type: Letter

References (9)

1. Conference report: Recommendations for the use of inactivated vaccines and other preventive measures
2. Effectiveness of influenza vaccine in healthcare professionals. A randomized trial
3. Careless doctors are dangerous for their patients
4. GPs can improve their handwashing habits
5. Approaches to improved influenza vaccination
6. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection
7. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM(TM) vaccines and conventional vaccines
8. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant
9. Influenza vaccines: A main problem in control of pandemics